Galapagos NV
GLPG
$33.39
$0.682.08%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
8/2/2025
-
Ticker Report
7/24/2025
-
TipRanks Financial Blog
7/23/2025
-
TipRanks Financial Blog
7/23/2025
-
Globe Newswire
7/23/2025
-
Globe Newswire
7/23/2025
-
Globe Newswire
6/26/2025
-
ETF Channel
6/25/2025
-
Ticker Report
6/23/2025
-
Market News Video
6/23/2025
-
Globe Newswire
6/18/2025
-
Globe Newswire
6/13/2025
-
TipRanks Financial Blog
6/12/2025
-
Globe Newswire
6/12/2025
-
MarketBeat
6/5/2025
-
MarketBeat
5/30/2025
-
MarketBeat
5/27/2025
-
Globe Newswire
5/21/2025
-
ETF Channel
5/20/2025
-
MarketBeat
5/20/2025
-
MarketBeat
5/19/2025
-
MarketBeat
5/16/2025
-
MarketBeat
5/14/2025
-
Globe Newswire
5/13/2025
-
Globe Newswire
5/9/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, July 24, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Oct 27 and 31 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
32 1 534 29 00
Address
Generaal De Wittelaan L11 A3
Mechelen, 2800
Mechelen, 2800
Country
Year Founded
Business Description
Sector
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667 that has...
more